Dallas, Texas (PRWEB) October 04, 2012
The report “Early Toxicology Markets and Approaches” focuses on markets for early toxicology testing services. The objective of this report is to focus the reader’s attention on the issues and opportunities related to early toxicology testing in drug discovery. Early toxicology testing market report begins with an overview of drug discovery, ADMET, and early toxicology testing. It continues with some of the ways big pharmaceutical developers deal with early toxicology. Several areas are covered, including:
For the purposes of reporting market size and growth forecasts, the report segments the market into the following:
- In Silico Approaches
o Data Mining Tools
- In Vitro Assays and Platforms
o Biochemical Assays
o Cellular Assays
o Instruments & Platforms
- In Vivo Testing
o Mice & Traditional Animals
o Zebrafish Models
o Other Animals
o Human Microdosing
- Early Tox Services
o In Silico Services
o In Vitro Services
o In Vivo Services
Market analysis in this report considers primarily the availability of products, number and type of clinical trials active, primary endpoints, and development of new products. The market focuses on the United States region and, where available, discusses the market globally. All sales are displayed at the manufacturers’ level in U.S. dollars. Although the sales figures are displayed at the manufacturers’ level, in many instances, this figure represents a close comparison to the retail level as many end users are purchasing directly from the manufacturer. The base year is 2011, with forecasts provided for each year through 2016.
As part of the report's detailed coverage, the following companies are profiled:
- Albany Molecular
- BD Biosciences
- Beckman Coulter
- Caliper Life Sciences
- Charles River
- GE Biosciences
- Gene Logic
- Ingenuity Systems
- Life Technologies (Invitrogen)
- Simulations Plus
- Thermo Fisher
The World Market for Transdermal Drug Delivery is a comprehensive look at the transdermal / transmucosal drug delivery market and the report is divided into two sections. The first section encompasses the pharmaceutical products that utilize the drug delivery technology. The second section encompasses drug delivery technology and the revenues earned from licensing that technology. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales for products utilizing that technology.
This report covers:
- Market Size and Forecast for Transdermal Drug Delivery
- Market Size and Forecast for Transmucosal Drug Delivery
- Market Breakout by Region (US, Europe, Japan, ROW)
- Review of Products on the Market
- Market Breakout by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking Cessation, Other)
- Market Breakout by Technology Revenues and Pharmaceutical Component Revenues
- Profiles of Companies in the Market
The research includes comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and database searches, as well as via interviews with key personnel. Person-to-person and telephone interviews were the primary method of gathering information. E-mail correspondence was also used in the interview process. Interviews with 18 key industry officials, trade association representatives, consultants, healthcare providers, and government personnel were compiled to form the primary basis of information—particularly revenue and market share data—presented in this report.
All market data pertain to the worldwide market at the manufacturers’ level and presented in U.S. dollars. The base year for data was 2012. Historical data are provided for 2010 through 2011, with forecast data provided for 2013 through 2017. Compound annual growth rates (CAGR) are provided for the 2010-2012, 2012-2017, and 2010–2017 periods.
The following companies are profiled in this report
- 3M Pharmaceuticals
- Access Pharmaceuticals, Inc.
- Acrux Limited
- ALZA Corporation
- Antares Pharma, Inc.
- Apricus BioSciences
- Aveva Drug Delivery Systems
- Generex Biotechnology Corporation
- Inovio Pharmaceuticals, Inc.
- Labtec GmbH
- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
- NITTO DENKO CORPORATION
- Noven Pharmaceuticals, Inc.
- Pantec Biosolutions AG
- TEVA Pharmaceutical Industries Ltd.
- Zosano Pharma
Contact email@example.com for further information.
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of 5000+ micro markets.